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Dcommissural leaflet, MR was controlled by inverting the
prolapsed leaflet into the left ventricle and annuloplasty
and repair of the prolapsed posterior leaflet. In cases with
a prolapsed A1 or A3 segment, 1 arm of the suture was
placed on the free edge of the prolapsed leaflet, and the
other armwas brought out to the anterolateral or posterome-
dial annulus to invert a part of the prolapsed anterior seg-
ment. Annuloplasty was not always applied to the anterior
leaflet. As needed, artificial chordae were added to adjust
the leaflet height.
The simplicity and reproducibility of this technique make
it a potentially attractive alternative for minimally invasive,
endoscopic, and robotic mitral valve procedures. Also, the
reversibility of this technique provides a chance for resi-
dents to gain experience in mitral valve repair.
A potential risk of infection or thromboembolism exists,
related to the inverted tissue. We have had no infection or
thromboembolism to date. Anticoagulation with warfarin
(Coumadin sodium) was continued for 2 months only after
surgery unless the patient had an indication for long-term
anticoagulation.
The limitations of this repair include that it might be dif-
ficult to apply this technique to calcified leaflets. It might not
be possible to apply this technique to the A2 segment, and
artificial chordae will still be required for some cases with
a prolapsed anterior leaflet. The present studywas retrospec-
tive, and the duration of follow-up was short (<5 years). A
larger patient series and long-term follow-up are necessary
to assess the efficacy and durability of this technique.
CONCLUSIONS
FMVR is an easy technique without resection for repair
of the prolapsed mitral valve. The propalsed segment was
inverted into the left ventricle vertically with a pilot suture,
which can be easily removed and repositioned, if unsatis-
factory. This reversibility is a significant advantage of this
technique. Good short-term outcomes were observed.
This technique can also be applied to anterior leaflet patho-
logic entities in selected patients.
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Dr D. Craig Miller (Stanford, Calif). Dr Tsukui, welcome to
Hawaii and theWestern Thoracic Surgical. Very nice presentation,
paper, and video.
I have 2 comments and 2 questions. Number 1 is a comment.
This was an elegant presentation, but we must remember that
what you are calling ‘‘foldoplasty’’ is not new. It is actually
a very old technique, analogous to what Dwight McGoon pio-
neered 50 years ago at the Mayo Clinic. What you are showing
is very similar, but why are we trying to reincarnate these ancient
McGoon techniques today? TheMcGoon ‘‘V-excision’’ repair had
been abandoned everywhere, except at the Mayo Clinic, until the
last decade when it was resurrected by Tommy Mihaljevic, the
New York University group, and Larry Cohen. More recently,
Joe Woo at Pennsylvania published a repair technique very similar
to yours in the Journal of Thoracic and Cardiovascular Surgery,
which I call the ‘‘dunkoplasty,’’ where you just bury the excess
posterior scallop prolapse down inside the ventricle. The question
remains—why are some groups reincarnating these old tech-
niques? I will get to this in a minute.
A couple questions now. What is your patient follow-up magni-
tude and extent? You have been doing this for about 5 years, but I
did not see any follow-up mentioned in the paper. I did not see any
1-year or 2-year echocardiographic results, nor did I see any 1-year
or 2-year echocardiographic results. How can we judge if your ap-
proach has merit if we do not know the follow-up and at least the
short-term echocardiographic results?
Dr Tsukui. Thank you very much for your questions. As you
pointed out, this is a type ofMcGoon technique, which was already
performed before. Our concept is a little bit different from that of
Dr Cohen’s or Dr Woo’s, because our stitch is really easy to re-
move after being placed. In addition, Dr Cohen’s technique is
a horizontal technique, but our technique is vertical. The reason
we started this technique for mitral valve regurgitation is it is easier
to teach the residents. Once a resident cuts the mitral valve inap-
propriately, we cannot fix it, but if we use this technique, we can
repair the valve again after removing the pilot stitch. That is
why we started this technique.
As you pointed out, we do not have long-term outcomes yet.
The oldest one is just 4 years. Now we are examining echocardio-
graphic data for mitral valve at our outpatient clinic, and we did not
have significant mitral regurgitation (MR), as I showed here. Also,
we are checking the B-type natriuretic peptide level, whichery c January 2013
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Dshowed improvement of heart failure. I could not show the B-type
natriuretic peptide level data today, but I would like to show you at
the next WTSA [Western Thoracic Surgical Association] annual
meeting.
Dr Miller. Okay, that is interesting, because it leads to my next
question. Because most of your patients were asymptomatic or
minimally symptomatic, New York Heart Association class I or
II preoperatively, is having 20% of patients have residual mild
MR at hospital discharge acceptable quality? I do not believe
that result will help us convince cardiologists that early repair
for asymptomatic patients is justified. You can almost get that
good a repair with an Abbott MitraClip or 2, at about
$US20,000 a pop. Is that really satisfactory surgical quality?
Dr Tsukui. This is my personal impression, but cardiologists’
evaluations are really tough for cardiac surgeons. They diagnose
even really small regurgitation as ‘‘mild’’ MR after surgery. I am
not sure, but if we do not have any progression of MR for a couple
of years after surgery, we could tell this technique is effective. We
will see in the next couple years.
Dr Miller. Good. That is what I was asking for—late echocar-
diographic results. I am surprised the B-type natriuretic peptide
levels were elevated preoperatively, because most of your patients
really did not have many symptoms. Perhaps you could put those
data in your paper when Dr Cohen gives you the chance to revise it.
This leads me to my chief comment, which is something we all
should do some soul searching about. Why are we striving to bring
back these older, simpler techniques?Was not theMcGoon ‘‘V-ex-
cision’’ judged long ago to be obsolete, except at the Mayo Clinic?
Only recently, coupled with the advent of robotic mitral surgery,
has it resurfaced and is now in vogue in Cleveland and Ranny Chit-
wood’s center in East Greenville, North Carolina? These old
methods had been jettisoned over the years and replaced by newer
resectional methods, ‘‘slidingplasty,’’ and the Gore-Tex neochord
techniques at most experienced mitral centers. Has the resurgence
of interest in ‘‘folding plasty’’ and/or simple McGoon
‘‘V-excision’’ just been due to the stampede to perform surgery
through a smaller hole or with robotic assistance? Why should
we compromise our surgical approach and our surgical outcome
standards just to do something more quickly using minimal inva-
sively approaches? This worries me. Additionally, to make the re-
pair simpler (or ‘‘dumb it down’’) so that it can be applied just to
raise the 69% national rate of repair to 90% bymore surgeons, who
do not see a lot of mitral valve cases—recall that the average num-
ber of mitral repair or replacement operations performed is only 5
per US surgeon annually—could backfire and come back to
haunt us if the results are not as good as that reported from the
high-volume centers. I tell David Adams every time I seeThe Journal of Thoracic and Cahim he is being unrealistic when he tells all of us that we must re-
pair at least 95% of regurgitant mitral valves. Marc Gillinov has
shown clearly that a good mitral replacement is much better than
a suboptimal repair. We simply cannot afford to compromise our
surgical repair outcomes. The cardiologists are lurking to jump
on this and will claim your repair results are no better than those
with a MitraClip. We must remember that our surgical goal, espe-
cially in patients with asymptomatic or minimally symptomatic
prolapse, is to have a nearly perfect repair and show our cardiolo-
gists satisfactory echocardiographic results 10 or more years later.
If we do not achieve that goal, we are not giving our patients the
best solution to their problem. I am already concerned that the re-
sults of mitral valve repair are deteriorating nationwide in the
United States; yes, more repairs are being done, but the results
might not be as good as earlier reported from high-volume mitral
institutions. If this is true, the cardiologists are going to see this as
an opportunity to do something with an intervention because our
standards have slipped to a point at which they might be able to
equal them.
In summary, we look forward to you coming back in a few years
with the 5-year echocardiographic results that will demonstrate
whether this simplified technique has merit. Congratulations on
a nice presentation. Thank you.
Dr Tsukui. Thank you.
Dr Scott McClure (Boston, Mass). Nice presentation. As Dr
Miller just alluded, at the Brigham, Dr Cohn will often use and
teach a ‘‘folding plasty’’ repair, in which he folds the posterior leaf-
let back from the free edge to the annulus. For years, Dr Sari Aranki
at the Brigham has used a repair technique that seems quite similar
towhat you have described today, in which he invaginates a portion
of the posterior leaflet downward into the left ventricular cavity.
When deciding whether to use their ‘‘folding plasty’’ repairs, Drs
Cohn and Aranki generally differentiate between those patients
who have myxomatous disease with elongated chords and those
withmyxomatous disease and ruptured chords. Barring the odd ex-
ception to the rule, they would tend to perform a leaflet resection if
they identified any major ruptured chords within the prolapsing
segment of the leaflet. My question is this: I just want to know
whether a similar distinction ismade at your center before perform-
ing a ‘‘folding plasty’’ or whether you use this technique in the
presence of both elongated and rupture chords indiscriminately?
Dr Tsukui. Thank you for the question. For the ruptured chor-
dae case, we applied the ‘‘folding plasty’’ technique first. Some-
times, as you pointed out, we still have prolapse owing to the
ruptured chordae. At that time, we place artificial chordae to
pull the prolapsed leaflet down to the left ventricle or, as you
pointed out, we cut it out, if it is really large.rdiovascular Surgery c Volume 145, Number 1 109
